暗記メーカー

暗記メーカー

​
ログイン
CHARACTERISTICS OF CLOTTING FACTORS
100問 • 2年前
  • Yves Laure Pimentel
    • 通報

    問題一覧

  • 1

    most concentrated of all the plasma procoagulants

    FACTOR I FIBRINOGEN

  • 2

    FACTOR I

    FIBRINOGEN

  • 3

    FIBRINOGEN MOL WEIGHT (DALTONS)

    340,000

  • 4

    FIBRINOGEN half life (hours)

    100 to 150

  • 5

    FIBRINOGEN mean plasma concentration

    200 to 400 mg/dL

  • 6

    is fibrinogen level is ? PT and APTT will be prolonged

    <100 mg/dL

  • 7

    it is essential for platelet aggregation (links activated platelets through their GP IIB/IIIA platelet fibrinogen receptor)

    FACTOR I FIBRINOGEN

  • 8

    increases approximately how many mg /dL per decade in the elderly

    10 mg/dL

  • 9

    Factor II

    Prothrombin

  • 10

    Factor II Prothrombin Mol. weight (Daltons)

    71,600

  • 11

    Factor II Prothrombin half life (hours)

    60

  • 12

    Factor II Prothrombin Mean plasma concentration

    10 mg/dL

  • 13

    FACTOR III

    Tissue Factor Tissue thromboplastin Thrombokinase

  • 14

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase mol. weight (Daltons)

    44,000

  • 15

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase half life hours

    insoluble

  • 16

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase mean plasma concentration

    none

  • 17

    enters when there is Vascular injury

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase

  • 18

    originates from the tissues

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase

  • 19

    FACTOR IV

    CALCIUM IONS/ IONIZED CALCIUM

  • 20

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM Mol. weight ( Daltons)

    40

  • 21

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM half life (hours)

    N/A

  • 22

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM Mean plasma concentration

    8-10 mg dL

  • 23

    chelated by in vitro anticoagulants EDTA SODIUM CITRATE

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM

  • 24

    FACTOR IV CALCIUM IONS chelated by in vitro anticoagulants

    EDTA SODIUM CITRATE

  • 25

    FACTOR V

    Proacceclerin Labile factor thrombogen

  • 26

    FACTOR V Proacceclerin Labile factor thrombogen Mol. weight ( Daltons)

    330,000

  • 27

    FACTOR V Proacceclerin Labile factor thrombogen half life (hours)

    24

  • 28

    FACTOR V Proacceclerin Labile factor thrombogen mean plasma concentration

    1 mg/dL

  • 29

    mutant factor V ( Dutch investigator first described this mutation)

    Factor V Leiden

  • 30

    are inactivated by protein C - protein S complex

    Factor V AND VIII

  • 31

    deficiency of factor V is

    Owrens Disease or Para hemophilia

  • 32

    Factor VII

    Proconvertin/ Stable Factor

  • 33

    Factor VII Proconvertin/ Stable Factor Mol. weight ( Daltons)

    50,000

  • 34

    Factor VII Proconvertin/ Stable Factor half life (Hours)

    6

  • 35

    Factor VII Proconvertin/ Stable Factor Mean Plasma Concentration

    0.05 mg/dL

  • 36

    first coagulation Factor to be affected by Warfarin Therapy

    Factor VII Proconvertin/ Stable Factor

  • 37

    an oral anticoagulant

    Warfarin Therapy

  • 38

    has the shortest half life

    FACTOR VII PROCONVERTIN STABLE FACTOR 6

  • 39

    FACTOR VIII

    ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG)

  • 40

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) mol. weight (Daltons):

    330,000

  • 41

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) half life (hours )

    12 hours

  • 42

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) Mean plasma concentration

    0.01 mg/dL

  • 43

    it is unstable in plasma (it circulates bount to VWF). During the coagulation, thrombin cleaves it from VWF and activates it

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG)

  • 44

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) DEFICIENCY

    HEMOPHILIA A OR CLASSIC HEMOPHILIA

  • 45

    refers to the antigenic properties

    Factor VIII: Ag

  • 46

    measured by immunoassays

    Factor VIII: Ag

  • 47

    refers to procoagulant portion

    FACTOR VIII, FACTOR VIIIC, FACTOR VIII:C

  • 48

    measured by standard FACTOR VIII assays and APTT

    FACTOR VIII, FACTOR VIIIC, FACTOR VIII:C

  • 49

    markedly decreased in hemophilia A

    FACTOR VIII, FACTOR VIIIC, FACTOR VIII:C

  • 50

    refers to the portion responsible for platelet aggregation in the presence of RISTOCETIN

    FACTOR VIIIR:RCo

  • 51

    termed as RISTOCETIN cofactor

    FACTOR VIIIR:RCo

  • 52

    also termed the Von Willebrand Factor

    Factor VIII: VWF

  • 53

    required for normal platelet adhesion

    Factor VIII: VWF

  • 54

    antigenic portion of the Von Willebrand Factor

    vWF:Ag

  • 55

    was previously termed Factor VIII related antigen (VIIIR:Ag)

    vWF:Ag

  • 56

    vWF aka

    von Willebrand Factor

  • 57

    largest molecule in the human plasma

    von Willebrand Factor

  • 58

    has receptor sites for both platelets and collagen ( helps to bind platelets to exposed subendothelial collagen during platelet adhesion)

    von Willebrand Factor

  • 59

    primary platelet surface receptor for von Willebrand Factor

    GP IB/IX/V

  • 60

    von Willebrand Factor mol. weight ( Daltons)

    600,000 to 20,000,000

  • 61

    von Willebrand Factor half life ( hours)

    24

  • 62

    von Willebrand Factor mean plasma concentration

    1 mg/dL

  • 63

    FACTOR IX

    CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC)

  • 64

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY

    Hemophilia B or Christmas Disease

  • 65

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) mol. weight ( Daltons)

    57,000

  • 66

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) half life

    24

  • 67

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) mean Plasma Concentration

    0.3 mg/dL

  • 68

    participant in common pathway

    FACTOR X STUART PROWER FACTOR

  • 69

    FACTOR X

    STUART PROWER FACTOR

  • 70

    FACTOR X STUART PROWER FACTOR mol. weight ( Daltons)

    58,800

  • 71

    FACTOR X STUART PROWER FACTOR half life (hours)

    48 to 52

  • 72

    FACTOR X STUART PROWER FACTOR Mean Plasma Concentration

    1 mg/dL

  • 73

    FACTOR XI

    ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA)

  • 74

    >50 % cases seen in Ashkenazi Jews

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA)

  • 75

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) % cases seen in

    50% cases seen in Ashkenazi Jews

  • 76

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) deficiency

    HEMOPHILIA C OR ROSENTHAL SYNDROME

  • 77

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) Mol. weight (Daltons)

    143,000

  • 78

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) half life (hours)

    48 to 84

  • 79

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) mean plasma concentration

    0.5 mg/dL

  • 80

    FACTOR XII

    HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR

  • 81

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR Mol weight ( Daltons)

    84,000

  • 82

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR half life (hours)

    48 to 70

  • 83

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR mean plasma concentration

    3 mg /dL

  • 84

    deficiency: has no bleeding tendency has thrombotic tendency

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR

  • 85

    FACTOR XIII

    FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR

  • 86

    it uses 5 M urea to detect clot solubility test

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR

  • 87

    5M urea clot solubility test aka

    Duckert's Test

  • 88

    not detected by PT and APTT

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR

  • 89

    if clot is soluble in 5M urea =

    Factor XIII Deficiency

  • 90

    if clot is insoluble in 5M urea=

    FACTOR XIII is present

  • 91

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR mol. weight (Daltons)

    320,000

  • 92

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR half life (hours)

    150

  • 93

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR mean plasma concentration

    2 mg/dL

  • 94

    PK

    Prekallikrein aka Fletcher FACTOR

  • 95

    PK Prekallikrein aka Fletcher FACTOR mol. weight Daltons

    85,000

  • 96

    PK Prekallikrein aka Fletcher FACTOR half life (hours)

    35

  • 97

    PK Prekallikrein aka Fletcher FACTOR mean plasma concentration

    35 to 50 ug/mL

  • 98

    HMWK

    HIGH MOLECULAR WEIGHT KININOGEN / REID FACTOR/ WILLIAMS FACTOR/ FITZGERALD FACTOR/ FLAUJEAC FACTOR

  • 99

    (HMWK) HIGH MOLECULAR WEIGHT KININOGEN / REID FACTOR/ WILLIAMS FACTOR/ FITZGERALD FACTOR/ FLAUJEAC FACTOR mol weight

    120,000

  • 100

    (HMWK) HIGH MOLECULAR WEIGHT KININOGEN / REID FACTOR/ WILLIAMS FACTOR/ FITZGERALD FACTOR/ FLAUJEAC FACTOR half life and mean plasma concentration

    156 5 mg/dL

    • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    most concentrated of all the plasma procoagulants

    FACTOR I FIBRINOGEN

  • 2

    FACTOR I

    FIBRINOGEN

  • 3

    FIBRINOGEN MOL WEIGHT (DALTONS)

    340,000

  • 4

    FIBRINOGEN half life (hours)

    100 to 150

  • 5

    FIBRINOGEN mean plasma concentration

    200 to 400 mg/dL

  • 6

    is fibrinogen level is ? PT and APTT will be prolonged

    <100 mg/dL

  • 7

    it is essential for platelet aggregation (links activated platelets through their GP IIB/IIIA platelet fibrinogen receptor)

    FACTOR I FIBRINOGEN

  • 8

    increases approximately how many mg /dL per decade in the elderly

    10 mg/dL

  • 9

    Factor II

    Prothrombin

  • 10

    Factor II Prothrombin Mol. weight (Daltons)

    71,600

  • 11

    Factor II Prothrombin half life (hours)

    60

  • 12

    Factor II Prothrombin Mean plasma concentration

    10 mg/dL

  • 13

    FACTOR III

    Tissue Factor Tissue thromboplastin Thrombokinase

  • 14

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase mol. weight (Daltons)

    44,000

  • 15

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase half life hours

    insoluble

  • 16

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase mean plasma concentration

    none

  • 17

    enters when there is Vascular injury

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase

  • 18

    originates from the tissues

    FACTOR III Tissue Factor Tissue thromboplastin Thrombokinase

  • 19

    FACTOR IV

    CALCIUM IONS/ IONIZED CALCIUM

  • 20

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM Mol. weight ( Daltons)

    40

  • 21

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM half life (hours)

    N/A

  • 22

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM Mean plasma concentration

    8-10 mg dL

  • 23

    chelated by in vitro anticoagulants EDTA SODIUM CITRATE

    FACTOR IV CALCIUM IONS/ IONIZED CALCIUM

  • 24

    FACTOR IV CALCIUM IONS chelated by in vitro anticoagulants

    EDTA SODIUM CITRATE

  • 25

    FACTOR V

    Proacceclerin Labile factor thrombogen

  • 26

    FACTOR V Proacceclerin Labile factor thrombogen Mol. weight ( Daltons)

    330,000

  • 27

    FACTOR V Proacceclerin Labile factor thrombogen half life (hours)

    24

  • 28

    FACTOR V Proacceclerin Labile factor thrombogen mean plasma concentration

    1 mg/dL

  • 29

    mutant factor V ( Dutch investigator first described this mutation)

    Factor V Leiden

  • 30

    are inactivated by protein C - protein S complex

    Factor V AND VIII

  • 31

    deficiency of factor V is

    Owrens Disease or Para hemophilia

  • 32

    Factor VII

    Proconvertin/ Stable Factor

  • 33

    Factor VII Proconvertin/ Stable Factor Mol. weight ( Daltons)

    50,000

  • 34

    Factor VII Proconvertin/ Stable Factor half life (Hours)

    6

  • 35

    Factor VII Proconvertin/ Stable Factor Mean Plasma Concentration

    0.05 mg/dL

  • 36

    first coagulation Factor to be affected by Warfarin Therapy

    Factor VII Proconvertin/ Stable Factor

  • 37

    an oral anticoagulant

    Warfarin Therapy

  • 38

    has the shortest half life

    FACTOR VII PROCONVERTIN STABLE FACTOR 6

  • 39

    FACTOR VIII

    ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG)

  • 40

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) mol. weight (Daltons):

    330,000

  • 41

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) half life (hours )

    12 hours

  • 42

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) Mean plasma concentration

    0.01 mg/dL

  • 43

    it is unstable in plasma (it circulates bount to VWF). During the coagulation, thrombin cleaves it from VWF and activates it

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG)

  • 44

    FACTOR VIII ANTIHEMOPHILIC FACTOR A (AHF-A)/ ANTIHEMOPHILIC GLOBULIN (AHG) DEFICIENCY

    HEMOPHILIA A OR CLASSIC HEMOPHILIA

  • 45

    refers to the antigenic properties

    Factor VIII: Ag

  • 46

    measured by immunoassays

    Factor VIII: Ag

  • 47

    refers to procoagulant portion

    FACTOR VIII, FACTOR VIIIC, FACTOR VIII:C

  • 48

    measured by standard FACTOR VIII assays and APTT

    FACTOR VIII, FACTOR VIIIC, FACTOR VIII:C

  • 49

    markedly decreased in hemophilia A

    FACTOR VIII, FACTOR VIIIC, FACTOR VIII:C

  • 50

    refers to the portion responsible for platelet aggregation in the presence of RISTOCETIN

    FACTOR VIIIR:RCo

  • 51

    termed as RISTOCETIN cofactor

    FACTOR VIIIR:RCo

  • 52

    also termed the Von Willebrand Factor

    Factor VIII: VWF

  • 53

    required for normal platelet adhesion

    Factor VIII: VWF

  • 54

    antigenic portion of the Von Willebrand Factor

    vWF:Ag

  • 55

    was previously termed Factor VIII related antigen (VIIIR:Ag)

    vWF:Ag

  • 56

    vWF aka

    von Willebrand Factor

  • 57

    largest molecule in the human plasma

    von Willebrand Factor

  • 58

    has receptor sites for both platelets and collagen ( helps to bind platelets to exposed subendothelial collagen during platelet adhesion)

    von Willebrand Factor

  • 59

    primary platelet surface receptor for von Willebrand Factor

    GP IB/IX/V

  • 60

    von Willebrand Factor mol. weight ( Daltons)

    600,000 to 20,000,000

  • 61

    von Willebrand Factor half life ( hours)

    24

  • 62

    von Willebrand Factor mean plasma concentration

    1 mg/dL

  • 63

    FACTOR IX

    CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC)

  • 64

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY

    Hemophilia B or Christmas Disease

  • 65

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) mol. weight ( Daltons)

    57,000

  • 66

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) half life

    24

  • 67

    FACTOR IX CHRISTMAS FACTOR/ ANTIHEMOPHILIC FACTOR B (AHF-B)/ PLASMA THROMBOPLASTIN COMPONENT (PTC) mean Plasma Concentration

    0.3 mg/dL

  • 68

    participant in common pathway

    FACTOR X STUART PROWER FACTOR

  • 69

    FACTOR X

    STUART PROWER FACTOR

  • 70

    FACTOR X STUART PROWER FACTOR mol. weight ( Daltons)

    58,800

  • 71

    FACTOR X STUART PROWER FACTOR half life (hours)

    48 to 52

  • 72

    FACTOR X STUART PROWER FACTOR Mean Plasma Concentration

    1 mg/dL

  • 73

    FACTOR XI

    ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA)

  • 74

    >50 % cases seen in Ashkenazi Jews

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA)

  • 75

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) % cases seen in

    50% cases seen in Ashkenazi Jews

  • 76

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) deficiency

    HEMOPHILIA C OR ROSENTHAL SYNDROME

  • 77

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) Mol. weight (Daltons)

    143,000

  • 78

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) half life (hours)

    48 to 84

  • 79

    FACTOR XI ANTIHEMOPHILIC FACTOR C (AHF-C)/ PLASMA THROMBOPLASTIN ANTECEDENT (PTA) mean plasma concentration

    0.5 mg/dL

  • 80

    FACTOR XII

    HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR

  • 81

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR Mol weight ( Daltons)

    84,000

  • 82

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR half life (hours)

    48 to 70

  • 83

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR mean plasma concentration

    3 mg /dL

  • 84

    deficiency: has no bleeding tendency has thrombotic tendency

    FACTOR XII HAGEMAN FACTOR GLASS FACTOR CONTACT FACTOR

  • 85

    FACTOR XIII

    FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR

  • 86

    it uses 5 M urea to detect clot solubility test

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR

  • 87

    5M urea clot solubility test aka

    Duckert's Test

  • 88

    not detected by PT and APTT

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR

  • 89

    if clot is soluble in 5M urea =

    Factor XIII Deficiency

  • 90

    if clot is insoluble in 5M urea=

    FACTOR XIII is present

  • 91

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR mol. weight (Daltons)

    320,000

  • 92

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR half life (hours)

    150

  • 93

    FACTOR XIII FIBRIN STABILIZING FACTOR/ FIBRINASE/ LAKI-LORAND FACTOR mean plasma concentration

    2 mg/dL

  • 94

    PK

    Prekallikrein aka Fletcher FACTOR

  • 95

    PK Prekallikrein aka Fletcher FACTOR mol. weight Daltons

    85,000

  • 96

    PK Prekallikrein aka Fletcher FACTOR half life (hours)

    35

  • 97

    PK Prekallikrein aka Fletcher FACTOR mean plasma concentration

    35 to 50 ug/mL

  • 98

    HMWK

    HIGH MOLECULAR WEIGHT KININOGEN / REID FACTOR/ WILLIAMS FACTOR/ FITZGERALD FACTOR/ FLAUJEAC FACTOR

  • 99

    (HMWK) HIGH MOLECULAR WEIGHT KININOGEN / REID FACTOR/ WILLIAMS FACTOR/ FITZGERALD FACTOR/ FLAUJEAC FACTOR mol weight

    120,000

  • 100

    (HMWK) HIGH MOLECULAR WEIGHT KININOGEN / REID FACTOR/ WILLIAMS FACTOR/ FITZGERALD FACTOR/ FLAUJEAC FACTOR half life and mean plasma concentration

    156 5 mg/dL